About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Hepatitis Reports
›
Top Articles
Current Hepatitis Reports
0.3
(top 100%)
impact factor
328
(top 50%)
papers
1.1K
(top 50%)
citations
17
(top 50%)
h
-index
0.3
(top 100%)
impact factor
352
all documents
1.1K
doc citations
28
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Hepatitis B Therapy in Pregnancy
Current Hepatitis Reports
2010
61
2
Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and Interleukin-28B
Current Hepatitis Reports
2011
52
3
Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony
Current Hepatitis Reports
2010
51
4
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
Current Hepatitis Reports
2011
51
5
Hepatitis B and Renal Disease
Current Hepatitis Reports
2010
49
6
Hepatitis C virus outside the liver
Current Hepatitis Reports
2003
48
7
Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant
Current Hepatitis Reports
2012
40
8
The Role of Interferon in Hepatitis B Therapy
Current Hepatitis Reports
2010
37
9
HBV genotypes: Epidemiology and implications regarding natural history
Current Hepatitis Reports
2006
35
10
Hbsag seroclearance in the natural history of chronic hepatitis b infection
Current Hepatitis Reports
2006
31
11
Management of Hepatitis C Antiviral Therapy Adverse Effects
Current Hepatitis Reports
2011
31
12
Role of Sleep Disturbance in Chronic Hepatitis C Infection
Current Hepatitis Reports
2010
29
13
A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B
Current Hepatitis Reports
2010
29
14
Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B
Current Hepatitis Reports
2010
26
15
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
Current Hepatitis Reports
2011
25
16
Chronic hepatitis C and steatosis
Current Hepatitis Reports
2004
21
17
Current Management Strategies for Acute Esophageal Variceal Hemorrhage
Current Hepatitis Reports
2014
20
18
The epidemiology of hepatocellular carcinoma in hcv
Current Hepatitis Reports
2005
18
19
Hepatitis C in patients with psychiatric disease and substance abuse: Screening strategies and comanagement models of care
Current Hepatitis Reports
2003
15
20
Neurocognitive Effects of the Hepatitis C Virus
Current Hepatitis Reports
2009
14
21
Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinoma
Current Hepatitis Reports
2007
13
22
DILI: New Insights into Diagnosis and Management
Current Hepatitis Reports
2013
13
23
Hepatitis C viral kinetics in special populations
Current Hepatitis Reports
2008
12
24
Primary Sclerosing Cholangitis: Current and Future Management Strategies
Current Hepatitis Reports
2013
12
25
Managing hepatitis C in users of illicit drugs
Current Hepatitis Reports
2007
11
26
Management of Psychiatric Disease in Hepatitis C Treatment Candidates
Current Hepatitis Reports
2010
10
27
Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
Current Hepatitis Reports
2011
10
28
Steatosis, steatohepatitis: Review of effects on chronic hepatitis C
Current Hepatitis Reports
2002
9
29
Hepatitis C in veterans
Current Hepatitis Reports
2003
9
30
Health-related quality of life in HCV-infected patients
Current Hepatitis Reports
2007
9
31
Iron and hepatitis C
Current Hepatitis Reports
2004
8
32
Liver transplantation for HBV and management of reinfection
Current Hepatitis Reports
2005
8
33
Ribavirin: How Does it Work and is it Still Needed?
Current Hepatitis Reports
2011
8
34
Hepatitis B virus infection in HIV-infected persons
Current Hepatitis Reports
2004
7
35
Hepatitis B virus genotype: What should the clinician know?
Current Hepatitis Reports
2007
7
36
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Current Hepatitis Reports
2010
7
37
Combination Therapy for Chronic Hepatitis B: Current Indications
Current Hepatitis Reports
2011
7
38
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
Current Hepatitis Reports
2013
7
39
Impact of hepatitis C coinfection on cognitive outcomes in HIV-infected individuals
Current Hepatitis Reports
2007
6
40
Iron and Hepatitis C
Current Hepatitis Reports
2010
6
41
Epigenetic Regulation of Hepatitis B Virus Infection
Current Hepatitis Reports
2011
6
42
Alcoholic Hepatitis: Steroids vs. Pentoxifylline
Current Hepatitis Reports
2013
6
43
Can we identify liver fibrosis in HCV-infected patients without a liver biopsy?
Current Hepatitis Reports
2003
5
44
Recent peginterferon and ribavirin combination trials
Current Hepatitis Reports
2004
5
45
Hepatitis C virus infection in United States correctional institutions
Current Hepatitis Reports
2004
5
46
Hepatitis B and pregnancy
Current Hepatitis Reports
2009
5
47
HCV Response-Guided Therapy: Should Treatment Length Be Shortened or Extended?
Current Hepatitis Reports
2011
5
48
Partial Response to Entecavir and Tenofovir in Naïve Patients with Chronic Hepatitis B: Clinical Relevance and Management
Current Hepatitis Reports
2012
5
49
Management of Recalcitrant Autoimmune Hepatitis
Current Hepatitis Reports
2013
5
50
Global epidemiology of hcv infection
Current Hepatitis Reports
2005
4
site/software ©
exaly
; All materials licenced under
CC by-SA
.